|
|
Lycopene
and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle
progression and induction of differentiation in HL-60 leukemic cells
Amir H, Karas M, Giat J, Danilenko M, Levy R, Yermiahu T, Levy J, Sharoni Y
Department of Clinical Biochemistry, Faculty of Health Sciences,
Ben-Gurion University of the Negev, Beer-Sheva, Israel
Lycopene, the major tomato carotenoid, has been found to inhibit proliferation
of several types of cancer cells, including those of breast, lung, and
endometrium.
By extending the work to the HL-60 promyelocytic leukemia cell line, we aimed to
evaluate some mechanistic aspects of this effect.
Particularly, the possibility was examined that the antiproliferative action of
the carotenoid is associated with induction of cell differentiation.
Lycopene treatment resulted in a concentration-dependent reduction in HL-60 cell
growth as measured by [3H]thymidine incorporation and cell counting.
This effect was accompanied by inhibition of cell cycle progression in the G0/G1
phase as measured by flow cytometry.
Lycopene alone induced cell differentiation as measured by phorbol
ester-dependent reduction of nitro blue tetrazolium and expression of the cell
surface antigen CD14.
Results of several recent intervention studies with beta-carotene, which have
revealed no beneficial effects of this carotenoid, suggest that a single dietary
component cannot explain the anticancer effect of diets rich in vegetables and
fruits.
Thus another goal of our study was to examine whether lycopene has the ability
to synergize with other natural anticancer compounds, such as
1,25-dihydroxyvitamin D3, which when used alone are therapeutically active only
at high and toxic concentrations.
The combination of low concentrations of lycopene with 1,25-dihydroxyvitamin D3
exhibited a synergistic effect on cell proliferation and differentiation and an
additive effect on cell cycle progression.
Such synergistic antiproliferative and differentiating effects of lycopene and
other compounds found in the diet and in plasma may suggest the inclusion of the
carotenoid in the diet as a cancer-preventive measure.
PMID: 10227052 [PubMed - indexed for MEDLINE]
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12679162&dopt=Abstract
|